AAPL 165.4 -1.34 (-0.80%)MSFT 106.08 -1.4 (-1.30%)FB 144.04 -1.32 (-0.91%)ZNGA 3.71 +0.04 (+1.23%)NVDA 146.45 -1.46 (-0.99%)WBA 78.69 -0.4 (-0.51%)GOOG 1041.79 -8.01 (-0.76%)PIH 5 -0.12 (-2.34%)
AAPL 165.4 -1.34 (-0.80%)MSFT 106.08 -1.4 (-1.30%)FB 144.04 -1.32 (-0.91%)ZNGA 3.71 +0.04 (+1.23%)NVDA 146.45 -1.46 (-0.99%)WBA 78.69 -0.4 (-0.51%)GOOG 1041.79 -8.01 (-0.76%)PIH 5 -0.12 (-2.34%)

Balance Sheet ABMD Quote ABIOMED Inc

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
CashAndCashEqui 22 48 39
ShortTermInvest 110 164 191
Cash 132 212 230
AccountReceivab 32 43 54
Inventories 17 27 35
DeferredIncomeT 45 59 35
OtherCurrentAss 0 0 0
TotalCurrentAss 220 288 327
PPE 25 42 108
AccumulatedDepr -16 -19 -20
NetPPE 9 23 88
EquityAndOtherI 14 1 47
Goodwill 32 33 31
IntangibleAsset 15 15 14
OtherLTAssets 4 4 8
TotalNonCurrent 118 136 223
TotalAssets 338 424 550
ShortTermDebt 0 0 0
AccountsPayable 10 9 21
TaxesPayable 2 3 3
AccruedLiabilit 20 26 35
DeferredRevenue 7 9 10
OtherCurrentLia 0 0 0
TotalCurrentLia 39 47 70
Debt 0 0 0
DeferredTaxesLi 1 1 1
DeferredRevenue 0 0 0
OtherLTLiabilit 7 8 12
TotalNonCurrent 7 9 29
TotalLiabilitie 47 55 98
CommonStock 0 0 0
AdditionalPaidI 465 509 566
RetainedEarning -137 -99 -47
AccumulatedOthe -17 -15 -21
TotalStockholde 292 369 452
TotalLiabilitie 338 424 550
ABIOMED Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes ABIOMED Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.